Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Former Mentor Employee Claims Firm Could Reduce Silicone Implant “Bleed”

This article was originally published in The Gray Sheet

Executive Summary

A former engineer for Mentor says the company decided against upgrading its Memory Gel silicone breast implants with patches capable of decreasing silicone oil leaks, or "bleeds.

You may also be interested in...



Public Citizen Seeks Criminal Investigation Of Breast-Implant-Maker Mentor

Public Citizen has asked FDA to begin a criminal investigation into allegations that silicone-breast-implant-manufacturer Mentor failed to disclose potential safety problems with its implants, currently under review by the agency

Public Citizen Seeks Criminal Investigation Of Breast-Implant-Maker Mentor

Public Citizen has asked FDA to begin a criminal investigation into allegations that silicone-breast-implant-manufacturer Mentor failed to disclose potential safety problems with its implants, currently under review by the agency

FDA investigates claims by ex-Mentor engineer

The Mentor whistleblower who alleged his former employer decided against upgrading the patches on its Memory Gel implants to reduce silicone oil leakage says he spoke with FDA's Office of Criminal Investigations unit Dec. 19. The engineer, who requested anonymity, said a criminal investigator spoke with him at FDA's offices in Dallas for over an hour about the charges he first reported to the agency in August 2005 (1"The Gray Sheet" Dec. 12, 2005, p. 8). In addition to the claims about Mentor's decision not to update the patches on the Memory Gel, the former employee alleges that the company has not accurately reported the rupture rates of the implants. FDA has not contacted Mentor about an investigation, the company said in a statement. "All rupture complaints have been submitted and reviewed as part of the premarket review process," the firm says...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel